BioCardia, Inc. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
BioCardia, Inc. (BCDA) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 12-month period ending 2011-12-31, per its 10-K filed 2012-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2012-03-29
- BioCardia, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2011-12-31 was $0.00.
- BioCardia, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2010-12-31 was $0.00.
- BioCardia, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- BioCardia, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2010 was $5.28M.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $0.00 10-K · filed 2012-03-29 | |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-15 | ||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $5.28M 10-K · filed 2012-03-29 | |
| 2010-09-30 | $5.28M 10-Q · filed 2011-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |